|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:SERPINA1-TF (FusionGDB2 ID:80160) |
Fusion Gene Summary for SERPINA1-TF |
Fusion gene summary |
Fusion gene information | Fusion gene name: SERPINA1-TF | Fusion gene ID: 80160 | Hgene | Tgene | Gene symbol | SERPINA1 | TF | Gene ID | 5265 | 7018 |
Gene name | serpin family A member 1 | transferrin | |
Synonyms | A1A|A1AT|AAT|PI|PI1|PRO2275|alpha1AT|nNIF | HEL-S-71p|PRO1557|PRO2086|TFQTL1 | |
Cytomap | 14q32.13 | 3q22.1 | |
Type of gene | protein-coding | protein-coding | |
Description | alpha-1-antitrypsinalpha-1 antitrypsinalpha-1 protease inhibitoralpha-1-antiproteinasealpha-1-antitrypsin nullalpha-1-antitrypsin short transcript variant 1C4alpha-1-antitrypsin short transcript variant 1C5epididymis secretory sperm binding protein | serotransferrinbeta-1 metal-binding globulinepididymis secretory sperm binding protein Li 71psiderophilin | |
Modification date | 20200327 | 20200313 | |
UniProtAcc | . | GTF2A1L | |
Ensembl transtripts involved in fusion gene | ENST00000440909, ENST00000448921, ENST00000437397, ENST00000355814, ENST00000393087, ENST00000393088, ENST00000404814, ENST00000449399, ENST00000402629, ENST00000555289, | ENST00000402696, ENST00000264998, ENST00000475382, | |
Fusion gene scores | * DoF score | 28 X 24 X 6=4032 | 9 X 12 X 4=432 |
# samples | 28 | 13 | |
** MAII score | log2(28/4032*10)=-3.84799690655495 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(13/432*10)=-1.73251968913501 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: SERPINA1 [Title/Abstract] AND TF [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | SERPINA1(94848929)-TF(133472439), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | SERPINA1-TF seems lost the major protein functional domain in Tgene partner, which is a essential gene due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | TF | GO:0048260 | positive regulation of receptor-mediated endocytosis | 12704209 |
Fusion gene breakpoints across SERPINA1 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across TF (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | LIHC | TCGA-DD-A73C-01A | SERPINA1 | chr14 | 94848929 | - | TF | chr3 | 133472439 | + |
Top |
Fusion Gene ORF analysis for SERPINA1-TF |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
Frame-shift | ENST00000440909 | ENST00000402696 | SERPINA1 | chr14 | 94848929 | - | TF | chr3 | 133472439 | + |
5CDS-5UTR | ENST00000440909 | ENST00000264998 | SERPINA1 | chr14 | 94848929 | - | TF | chr3 | 133472439 | + |
5CDS-3UTR | ENST00000440909 | ENST00000475382 | SERPINA1 | chr14 | 94848929 | - | TF | chr3 | 133472439 | + |
Frame-shift | ENST00000448921 | ENST00000402696 | SERPINA1 | chr14 | 94848929 | - | TF | chr3 | 133472439 | + |
5CDS-5UTR | ENST00000448921 | ENST00000264998 | SERPINA1 | chr14 | 94848929 | - | TF | chr3 | 133472439 | + |
5CDS-3UTR | ENST00000448921 | ENST00000475382 | SERPINA1 | chr14 | 94848929 | - | TF | chr3 | 133472439 | + |
Frame-shift | ENST00000437397 | ENST00000402696 | SERPINA1 | chr14 | 94848929 | - | TF | chr3 | 133472439 | + |
5CDS-5UTR | ENST00000437397 | ENST00000264998 | SERPINA1 | chr14 | 94848929 | - | TF | chr3 | 133472439 | + |
5CDS-3UTR | ENST00000437397 | ENST00000475382 | SERPINA1 | chr14 | 94848929 | - | TF | chr3 | 133472439 | + |
Frame-shift | ENST00000355814 | ENST00000402696 | SERPINA1 | chr14 | 94848929 | - | TF | chr3 | 133472439 | + |
5CDS-5UTR | ENST00000355814 | ENST00000264998 | SERPINA1 | chr14 | 94848929 | - | TF | chr3 | 133472439 | + |
5CDS-3UTR | ENST00000355814 | ENST00000475382 | SERPINA1 | chr14 | 94848929 | - | TF | chr3 | 133472439 | + |
Frame-shift | ENST00000393087 | ENST00000402696 | SERPINA1 | chr14 | 94848929 | - | TF | chr3 | 133472439 | + |
5CDS-5UTR | ENST00000393087 | ENST00000264998 | SERPINA1 | chr14 | 94848929 | - | TF | chr3 | 133472439 | + |
5CDS-3UTR | ENST00000393087 | ENST00000475382 | SERPINA1 | chr14 | 94848929 | - | TF | chr3 | 133472439 | + |
In-frame | ENST00000393088 | ENST00000402696 | SERPINA1 | chr14 | 94848929 | - | TF | chr3 | 133472439 | + |
5CDS-5UTR | ENST00000393088 | ENST00000264998 | SERPINA1 | chr14 | 94848929 | - | TF | chr3 | 133472439 | + |
5CDS-3UTR | ENST00000393088 | ENST00000475382 | SERPINA1 | chr14 | 94848929 | - | TF | chr3 | 133472439 | + |
In-frame | ENST00000404814 | ENST00000402696 | SERPINA1 | chr14 | 94848929 | - | TF | chr3 | 133472439 | + |
5CDS-5UTR | ENST00000404814 | ENST00000264998 | SERPINA1 | chr14 | 94848929 | - | TF | chr3 | 133472439 | + |
5CDS-3UTR | ENST00000404814 | ENST00000475382 | SERPINA1 | chr14 | 94848929 | - | TF | chr3 | 133472439 | + |
In-frame | ENST00000449399 | ENST00000402696 | SERPINA1 | chr14 | 94848929 | - | TF | chr3 | 133472439 | + |
5CDS-5UTR | ENST00000449399 | ENST00000264998 | SERPINA1 | chr14 | 94848929 | - | TF | chr3 | 133472439 | + |
5CDS-3UTR | ENST00000449399 | ENST00000475382 | SERPINA1 | chr14 | 94848929 | - | TF | chr3 | 133472439 | + |
Frame-shift | ENST00000402629 | ENST00000402696 | SERPINA1 | chr14 | 94848929 | - | TF | chr3 | 133472439 | + |
5CDS-5UTR | ENST00000402629 | ENST00000264998 | SERPINA1 | chr14 | 94848929 | - | TF | chr3 | 133472439 | + |
5CDS-3UTR | ENST00000402629 | ENST00000475382 | SERPINA1 | chr14 | 94848929 | - | TF | chr3 | 133472439 | + |
intron-3CDS | ENST00000555289 | ENST00000402696 | SERPINA1 | chr14 | 94848929 | - | TF | chr3 | 133472439 | + |
intron-5UTR | ENST00000555289 | ENST00000264998 | SERPINA1 | chr14 | 94848929 | - | TF | chr3 | 133472439 | + |
intron-3UTR | ENST00000555289 | ENST00000475382 | SERPINA1 | chr14 | 94848929 | - | TF | chr3 | 133472439 | + |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000393088 | SERPINA1 | chr14 | 94848929 | - | ENST00000402696 | TF | chr3 | 133472439 | + | 3468 | 1201 | 1225 | 3081 | 618 |
ENST00000404814 | SERPINA1 | chr14 | 94848929 | - | ENST00000402696 | TF | chr3 | 133472439 | + | 3224 | 957 | 981 | 2837 | 618 |
ENST00000449399 | SERPINA1 | chr14 | 94848929 | - | ENST00000402696 | TF | chr3 | 133472439 | + | 3215 | 948 | 972 | 2828 | 618 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000393088 | ENST00000402696 | SERPINA1 | chr14 | 94848929 | - | TF | chr3 | 133472439 | + | 0.003575927 | 0.996424 |
ENST00000404814 | ENST00000402696 | SERPINA1 | chr14 | 94848929 | - | TF | chr3 | 133472439 | + | 0.003610776 | 0.99638927 |
ENST00000449399 | ENST00000402696 | SERPINA1 | chr14 | 94848929 | - | TF | chr3 | 133472439 | + | 0.003596729 | 0.99640334 |
Top |
Fusion Genomic Features for SERPINA1-TF |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
SERPINA1 | chr14 | 94848928 | - | TF | chr3 | 133472438 | + | 0.000317554 | 0.9996824 |
SERPINA1 | chr14 | 94848928 | - | TF | chr3 | 133472438 | + | 0.000317554 | 0.9996824 |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for SERPINA1-TF |
Go to FGviewer for the breakpoints of chr14:94848929-chr3:133472439 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
. | TF |
FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. | 478 |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | TF | chr14:94848929 | chr3:133472439 | ENST00000402696 | 1 | 17 | 361_683 | 72.0 | 699.0 | Domain | Transferrin-like 2 |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | SERPINA1 | chr14:94848929 | chr3:133472439 | ENST00000355814 | - | 2 | 5 | 368_392 | 215.33333333333334 | 419.0 | Region | Note=RCL |
Hgene | SERPINA1 | chr14:94848929 | chr3:133472439 | ENST00000393087 | - | 2 | 5 | 368_392 | 215.33333333333334 | 419.0 | Region | Note=RCL |
Hgene | SERPINA1 | chr14:94848929 | chr3:133472439 | ENST00000393088 | - | 4 | 7 | 368_392 | 215.33333333333334 | 419.0 | Region | Note=RCL |
Hgene | SERPINA1 | chr14:94848929 | chr3:133472439 | ENST00000402629 | - | 2 | 4 | 368_392 | 215.33333333333334 | 360.0 | Region | Note=RCL |
Hgene | SERPINA1 | chr14:94848929 | chr3:133472439 | ENST00000404814 | - | 3 | 6 | 368_392 | 215.33333333333334 | 419.0 | Region | Note=RCL |
Hgene | SERPINA1 | chr14:94848929 | chr3:133472439 | ENST00000437397 | - | 3 | 6 | 368_392 | 215.33333333333334 | 419.0 | Region | Note=RCL |
Hgene | SERPINA1 | chr14:94848929 | chr3:133472439 | ENST00000440909 | - | 2 | 5 | 368_392 | 215.33333333333334 | 419.0 | Region | Note=RCL |
Hgene | SERPINA1 | chr14:94848929 | chr3:133472439 | ENST00000448921 | - | 4 | 7 | 368_392 | 215.33333333333334 | 419.0 | Region | Note=RCL |
Hgene | SERPINA1 | chr14:94848929 | chr3:133472439 | ENST00000449399 | - | 3 | 6 | 368_392 | 215.33333333333334 | 419.0 | Region | Note=RCL |
Tgene | TF | chr14:94848929 | chr3:133472439 | ENST00000402696 | 1 | 17 | 25_347 | 72.0 | 699.0 | Domain | Transferrin-like 1 |
Top |
Fusion Gene Sequence for SERPINA1-TF |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>In-frame_ENST00000393088_ENST00000402696_TCGA-DD-A73C-01A_SERPINA1_chr14_94848929_-_TF_chr3_133472439_length(transcript)=3468nt_BP=1201nt GTGGGCAGGAACTGGGCACTGTGCCCAGGGCATGCACTGCCTCCACGCAGCAACCCTCAGAGTCCTGAGCTGAACCAAGAAGGAGGAGGG GGTCGGGCCTCCGAGGAAGGCCTAGCCGCTGCTGCTGCCAGGAATTCCAGGTTGGAGGGGCGGCAACCTCCTGCCAGCCTTCAGGCCACT CTCCTGTGCCTGCCAGAAGAGACAGAGCTTGAGGAGAGCTTGAGGAGAGCAGGAAAGGGCGGCAGTAAGTCTTCAGCATCAGGCATTTTG GGGTGACTCAGTAAATGGTAGATCTTGCTACCAGTGGAACAGCCACTAAGGATTCTGCAGTGAGAGCAGAGGGCCAGCTAAGTGGTACTC TCCCAGAGACTGTCTGACTCACGCCACCCCCTCCACCTTGGACACAGGACGCTGTGGTTTCTGAGCCAGGTACAATGACTCCTTTCGCAG CCTCCCCCGTTGCCCCTCTGGATCCACTGCTTAAATACGGACGAGGACAGGGCCCTGTCTCCTCAGCTTCAGGCACCACCACTGACCTGG GACAGTGAATCGACAATGCCGTCTTCTGTCTCGTGGGGCATCCTCCTGCTGGCAGGCCTGTGCTGCCTGGTCCCTGTCTCCCTGGCTGAG GATCCCCAGGGAGATGCTGCCCAGAAGACAGATACATCCCACCATGATCAGGATCACCCAACCTTCAACAAGATCACCCCCAACCTGGCT GAGTTCGCCTTCAGCCTATACCGCCAGCTGGCACACCAGTCCAACAGCACCAATATCTTCTTCTCCCCAGTGAGCATCGCTACAGCCTTT GCAATGCTCTCCCTGGGGACCAAGGCTGACACTCACGATGAAATCCTGGAGGGCCTGAATTTCAACCTCACGGAGATTCCGGAGGCTCAG ATCCATGAAGGCTTCCAGGAACTCCTCCGTACCCTCAACCAGCCAGACAGCCAGCTCCAGCTGACCACCGGCAATGGCCTGTTCCTCAGC GAGGGCCTGAAGCTAGTGGATAAGTTTTTGGAGGATGTTAAAAAGTTGTACCACTCAGAAGCCTTCACTGTCAACTTCGGGGACACCGAA GAGGCCAAGAAACAGATCAACGATTACGTGGAGAAGGGTACTCAAGGGAAAATTGTGGATTTGGTCAAGGAGCTTGACAGAGACACAGTT TTTGCTCTGGTGAATTACATCTTCTTTAAAGGCAAACGAAGCGGATGCTGTGACACTGGATGCAGGTTTGGTGTATGATGCTTACCTGGC TCCCAATAACCTGAAGCCTGTGGTGGCAGAGTTCTATGGGTCAAAAGAGGATCCACAGACTTTCTATTATGCTGTTGCTGTGGTGAAGAA GGATAGTGGCTTCCAGATGAACCAGCTTCGAGGCAAGAAGTCCTGCCACACGGGTCTAGGCAGGTCCGCTGGGTGGAACATCCCCATAGG CTTACTTTACTGTGACTTACCTGAGCCACGTAAACCTCTTGAGAAAGCAGTGGCCAATTTCTTCTCGGGCAGCTGTGCCCCTTGTGCGGA TGGGACGGACTTCCCCCAGCTGTGTCAACTGTGTCCAGGGTGTGGCTGCTCCACCCTTAACCAATACTTCGGCTACTCGGGAGCCTTCAA GTGTCTGAAGGATGGTGCTGGGGATGTGGCCTTTGTCAAGCACTCGACTATATTTGAGAACTTGGCAAACAAGGCTGACAGGGACCAGTA TGAGCTGCTTTGCCTGGACAACACCCGGAAGCCGGTAGATGAATACAAGGACTGCCACTTGGCCCAGGTCCCTTCTCATACCGTCGTGGC CCGAAGTATGGGCGGCAAGGAGGACTTGATCTGGGAGCTTCTCAACCAGGCCCAGGAACATTTTGGCAAAGACAAATCAAAAGAATTCCA ACTATTCAGCTCTCCTCATGGGAAGGACCTGCTGTTTAAGGACTCTGCCCACGGGTTTTTAAAAGTCCCCCCCAGGATGGATGCCAAGAT GTACCTGGGCTATGAGTATGTCACTGCCATCCGGAATCTACGGGAAGGCACATGCCCAGAAGCCCCAACAGATGAATGCAAGCCTGTGAA GTGGTGTGCGCTGAGCCACCACGAGAGGCTCAAGTGTGATGAGTGGAGTGTTAACAGTGTAGGGAAAATAGAGTGTGTATCAGCAGAGAC CACCGAAGACTGCATCGCCAAGATCATGAATGGAGAAGCTGATGCCATGAGCTTGGATGGAGGGTTTGTCTACATAGCGGGCAAGTGTGG TCTGGTGCCTGTCTTGGCAGAAAACTACAATAAGAGCGATAATTGTGAGGATACACCAGAGGCAGGGTATTTTGCTATAGCAGTGGTGAA GAAATCAGCTTCTGACCTCACCTGGGACAATCTGAAAGGCAAGAAGTCCTGCCATACGGCAGTTGGCAGAACCGCTGGCTGGAACATCCC CATGGGCCTGCTCTACAATAAGATCAACCACTGCAGATTTGATGAATTTTTCAGTGAAGGTTGTGCCCCTGGGTCTAAGAAAGACTCCAG TCTCTGTAAGCTGTGTATGGGCTCAGGCCTAAACCTGTGTGAACCCAACAACAAAGAGGGATACTACGGCTACACAGGCGCTTTCAGGTG TCTGGTTGAGAAGGGAGATGTGGCCTTTGTGAAACACCAGACTGTCCCACAGAACACTGGGGGAAAAAACCCTGATCCATGGGCTAAGAA TCTGAATGAAAAAGACTATGAGTTGCTGTGCCTTGATGGTACCAGGAAACCTGTGGAGGAGTATGCGAACTGCCACCTGGCCAGAGCCCC GAATCACGCTGTGGTCACACGGAAAGATAAGGAAGCTTGCGTCCACAAGATATTACGTCAACAGCAGCACCTATTTGGAAGCAACGTAAC TGACTGCTCGGGCAACTTTTGTTTGTTCCGGTCGGAAACCAAGGACCTTCTGTTCAGAGATGACACAGTATGTTTGGCCAAACTTCATGA CAGAAACACATATGAAAAATACTTAGGAGAAGAATATGTCAAGGCTGTTGGTAACCTGAGAAAATGCTCCACCTCATCACTCCTGGAAGC CTGCACTTTCCGTAGACCTTAAAATCTCAGAGGTAGGGCTGCCACCAAGGTGAAGATGGGAACGCAGATGATCCATGAGTTTGCCCTGGT TTCACTGGCCCAAGTGGTTTGTGCTAACCACGTCTGTCTTCACAGCTCTGTGTTGCCATGTGTGCTGAACAAAAAATAAAAATTATTATT GATTTTATATTTCAAAAACTCCATTCTTTCCTAAATATTTTCAACAAAGGATTTCTTTATGCATTCTGCCTAAATACCTATGCAACTGAG CCCTTCCTTCTCAGCTCAAGATTCGTCTGGTCTTTCCCTACAGCTTTGTGTGTGCCATGGCCACATCTCCTGGGTACAGTTCAAGGAGAC >In-frame_ENST00000393088_ENST00000402696_TCGA-DD-A73C-01A_SERPINA1_chr14_94848929_-_TF_chr3_133472439_length(amino acids)=618AA_start in transcript=1225_stop in transcript=3081 MDAGLVYDAYLAPNNLKPVVAEFYGSKEDPQTFYYAVAVVKKDSGFQMNQLRGKKSCHTGLGRSAGWNIPIGLLYCDLPEPRKPLEKAVA NFFSGSCAPCADGTDFPQLCQLCPGCGCSTLNQYFGYSGAFKCLKDGAGDVAFVKHSTIFENLANKADRDQYELLCLDNTRKPVDEYKDC HLAQVPSHTVVARSMGGKEDLIWELLNQAQEHFGKDKSKEFQLFSSPHGKDLLFKDSAHGFLKVPPRMDAKMYLGYEYVTAIRNLREGTC PEAPTDECKPVKWCALSHHERLKCDEWSVNSVGKIECVSAETTEDCIAKIMNGEADAMSLDGGFVYIAGKCGLVPVLAENYNKSDNCEDT PEAGYFAIAVVKKSASDLTWDNLKGKKSCHTAVGRTAGWNIPMGLLYNKINHCRFDEFFSEGCAPGSKKDSSLCKLCMGSGLNLCEPNNK EGYYGYTGAFRCLVEKGDVAFVKHQTVPQNTGGKNPDPWAKNLNEKDYELLCLDGTRKPVEEYANCHLARAPNHAVVTRKDKEACVHKIL -------------------------------------------------------------- >In-frame_ENST00000404814_ENST00000402696_TCGA-DD-A73C-01A_SERPINA1_chr14_94848929_-_TF_chr3_133472439_length(transcript)=3224nt_BP=957nt ATGCACTGCCTCCACGCAGCAACCCTCAGAGTCCTGAGCTGAACCAAGAAGGAGGAGGGGGTCGGGCCTCCGAGGAAGGCCTAGCCGCTG CTGCTGCCAGGAATTCCAGGTTGGAGGGGCGGCAACCTCCTGCCAGCCTTCAGGCCACTCTCCTGTGCCTGCCAGAAGAGACAGAGCTTG AGGAGAGCTTGAGGAGAGCAGGAAAGCCTCCCCCGTTGCCCCTCTGGATCCACTGCTTAAATACGGACGAGGACAGGGCCCTGTCTCCTC AGCTTCAGGCACCACCACTGACCTGGGACAGTGAATCGACAATGCCGTCTTCTGTCTCGTGGGGCATCCTCCTGCTGGCAGGCCTGTGCT GCCTGGTCCCTGTCTCCCTGGCTGAGGATCCCCAGGGAGATGCTGCCCAGAAGACAGATACATCCCACCATGATCAGGATCACCCAACCT TCAACAAGATCACCCCCAACCTGGCTGAGTTCGCCTTCAGCCTATACCGCCAGCTGGCACACCAGTCCAACAGCACCAATATCTTCTTCT CCCCAGTGAGCATCGCTACAGCCTTTGCAATGCTCTCCCTGGGGACCAAGGCTGACACTCACGATGAAATCCTGGAGGGCCTGAATTTCA ACCTCACGGAGATTCCGGAGGCTCAGATCCATGAAGGCTTCCAGGAACTCCTCCGTACCCTCAACCAGCCAGACAGCCAGCTCCAGCTGA CCACCGGCAATGGCCTGTTCCTCAGCGAGGGCCTGAAGCTAGTGGATAAGTTTTTGGAGGATGTTAAAAAGTTGTACCACTCAGAAGCCT TCACTGTCAACTTCGGGGACACCGAAGAGGCCAAGAAACAGATCAACGATTACGTGGAGAAGGGTACTCAAGGGAAAATTGTGGATTTGG TCAAGGAGCTTGACAGAGACACAGTTTTTGCTCTGGTGAATTACATCTTCTTTAAAGGCAAACGAAGCGGATGCTGTGACACTGGATGCA GGTTTGGTGTATGATGCTTACCTGGCTCCCAATAACCTGAAGCCTGTGGTGGCAGAGTTCTATGGGTCAAAAGAGGATCCACAGACTTTC TATTATGCTGTTGCTGTGGTGAAGAAGGATAGTGGCTTCCAGATGAACCAGCTTCGAGGCAAGAAGTCCTGCCACACGGGTCTAGGCAGG TCCGCTGGGTGGAACATCCCCATAGGCTTACTTTACTGTGACTTACCTGAGCCACGTAAACCTCTTGAGAAAGCAGTGGCCAATTTCTTC TCGGGCAGCTGTGCCCCTTGTGCGGATGGGACGGACTTCCCCCAGCTGTGTCAACTGTGTCCAGGGTGTGGCTGCTCCACCCTTAACCAA TACTTCGGCTACTCGGGAGCCTTCAAGTGTCTGAAGGATGGTGCTGGGGATGTGGCCTTTGTCAAGCACTCGACTATATTTGAGAACTTG GCAAACAAGGCTGACAGGGACCAGTATGAGCTGCTTTGCCTGGACAACACCCGGAAGCCGGTAGATGAATACAAGGACTGCCACTTGGCC CAGGTCCCTTCTCATACCGTCGTGGCCCGAAGTATGGGCGGCAAGGAGGACTTGATCTGGGAGCTTCTCAACCAGGCCCAGGAACATTTT GGCAAAGACAAATCAAAAGAATTCCAACTATTCAGCTCTCCTCATGGGAAGGACCTGCTGTTTAAGGACTCTGCCCACGGGTTTTTAAAA GTCCCCCCCAGGATGGATGCCAAGATGTACCTGGGCTATGAGTATGTCACTGCCATCCGGAATCTACGGGAAGGCACATGCCCAGAAGCC CCAACAGATGAATGCAAGCCTGTGAAGTGGTGTGCGCTGAGCCACCACGAGAGGCTCAAGTGTGATGAGTGGAGTGTTAACAGTGTAGGG AAAATAGAGTGTGTATCAGCAGAGACCACCGAAGACTGCATCGCCAAGATCATGAATGGAGAAGCTGATGCCATGAGCTTGGATGGAGGG TTTGTCTACATAGCGGGCAAGTGTGGTCTGGTGCCTGTCTTGGCAGAAAACTACAATAAGAGCGATAATTGTGAGGATACACCAGAGGCA GGGTATTTTGCTATAGCAGTGGTGAAGAAATCAGCTTCTGACCTCACCTGGGACAATCTGAAAGGCAAGAAGTCCTGCCATACGGCAGTT GGCAGAACCGCTGGCTGGAACATCCCCATGGGCCTGCTCTACAATAAGATCAACCACTGCAGATTTGATGAATTTTTCAGTGAAGGTTGT GCCCCTGGGTCTAAGAAAGACTCCAGTCTCTGTAAGCTGTGTATGGGCTCAGGCCTAAACCTGTGTGAACCCAACAACAAAGAGGGATAC TACGGCTACACAGGCGCTTTCAGGTGTCTGGTTGAGAAGGGAGATGTGGCCTTTGTGAAACACCAGACTGTCCCACAGAACACTGGGGGA AAAAACCCTGATCCATGGGCTAAGAATCTGAATGAAAAAGACTATGAGTTGCTGTGCCTTGATGGTACCAGGAAACCTGTGGAGGAGTAT GCGAACTGCCACCTGGCCAGAGCCCCGAATCACGCTGTGGTCACACGGAAAGATAAGGAAGCTTGCGTCCACAAGATATTACGTCAACAG CAGCACCTATTTGGAAGCAACGTAACTGACTGCTCGGGCAACTTTTGTTTGTTCCGGTCGGAAACCAAGGACCTTCTGTTCAGAGATGAC ACAGTATGTTTGGCCAAACTTCATGACAGAAACACATATGAAAAATACTTAGGAGAAGAATATGTCAAGGCTGTTGGTAACCTGAGAAAA TGCTCCACCTCATCACTCCTGGAAGCCTGCACTTTCCGTAGACCTTAAAATCTCAGAGGTAGGGCTGCCACCAAGGTGAAGATGGGAACG CAGATGATCCATGAGTTTGCCCTGGTTTCACTGGCCCAAGTGGTTTGTGCTAACCACGTCTGTCTTCACAGCTCTGTGTTGCCATGTGTG CTGAACAAAAAATAAAAATTATTATTGATTTTATATTTCAAAAACTCCATTCTTTCCTAAATATTTTCAACAAAGGATTTCTTTATGCAT TCTGCCTAAATACCTATGCAACTGAGCCCTTCCTTCTCAGCTCAAGATTCGTCTGGTCTTTCCCTACAGCTTTGTGTGTGCCATGGCCAC >In-frame_ENST00000404814_ENST00000402696_TCGA-DD-A73C-01A_SERPINA1_chr14_94848929_-_TF_chr3_133472439_length(amino acids)=618AA_start in transcript=981_stop in transcript=2837 MDAGLVYDAYLAPNNLKPVVAEFYGSKEDPQTFYYAVAVVKKDSGFQMNQLRGKKSCHTGLGRSAGWNIPIGLLYCDLPEPRKPLEKAVA NFFSGSCAPCADGTDFPQLCQLCPGCGCSTLNQYFGYSGAFKCLKDGAGDVAFVKHSTIFENLANKADRDQYELLCLDNTRKPVDEYKDC HLAQVPSHTVVARSMGGKEDLIWELLNQAQEHFGKDKSKEFQLFSSPHGKDLLFKDSAHGFLKVPPRMDAKMYLGYEYVTAIRNLREGTC PEAPTDECKPVKWCALSHHERLKCDEWSVNSVGKIECVSAETTEDCIAKIMNGEADAMSLDGGFVYIAGKCGLVPVLAENYNKSDNCEDT PEAGYFAIAVVKKSASDLTWDNLKGKKSCHTAVGRTAGWNIPMGLLYNKINHCRFDEFFSEGCAPGSKKDSSLCKLCMGSGLNLCEPNNK EGYYGYTGAFRCLVEKGDVAFVKHQTVPQNTGGKNPDPWAKNLNEKDYELLCLDGTRKPVEEYANCHLARAPNHAVVTRKDKEACVHKIL -------------------------------------------------------------- >In-frame_ENST00000449399_ENST00000402696_TCGA-DD-A73C-01A_SERPINA1_chr14_94848929_-_TF_chr3_133472439_length(transcript)=3215nt_BP=948nt CACGCAGCAACCCTCAGAGTCCTGAGCTGAACCAAGAAGGAGGAGGGGGTCGGGCCTCCGAGGAAGGCCTAGCCGCTGCTGCTGCCAGGA ATTCCAGGTTGGAGGGGCGGCAACCTCCTGCCAGCCTTCAGGCCACTCTCCTGTGCCTGCCAGAAGAGACAGAGCTTGAGGAGAGCTTGA GGAGAGCAGGAAAGCAGCCTCCCCCGTTGCCCCTCTGGATCCACTGCTTAAATACGGACGAGGACAGGGCCCTGTCTCCTCAGCTTCAGG CACCACCACTGACCTGGGACAGTGAATCGACAATGCCGTCTTCTGTCTCGTGGGGCATCCTCCTGCTGGCAGGCCTGTGCTGCCTGGTCC CTGTCTCCCTGGCTGAGGATCCCCAGGGAGATGCTGCCCAGAAGACAGATACATCCCACCATGATCAGGATCACCCAACCTTCAACAAGA TCACCCCCAACCTGGCTGAGTTCGCCTTCAGCCTATACCGCCAGCTGGCACACCAGTCCAACAGCACCAATATCTTCTTCTCCCCAGTGA GCATCGCTACAGCCTTTGCAATGCTCTCCCTGGGGACCAAGGCTGACACTCACGATGAAATCCTGGAGGGCCTGAATTTCAACCTCACGG AGATTCCGGAGGCTCAGATCCATGAAGGCTTCCAGGAACTCCTCCGTACCCTCAACCAGCCAGACAGCCAGCTCCAGCTGACCACCGGCA ATGGCCTGTTCCTCAGCGAGGGCCTGAAGCTAGTGGATAAGTTTTTGGAGGATGTTAAAAAGTTGTACCACTCAGAAGCCTTCACTGTCA ACTTCGGGGACACCGAAGAGGCCAAGAAACAGATCAACGATTACGTGGAGAAGGGTACTCAAGGGAAAATTGTGGATTTGGTCAAGGAGC TTGACAGAGACACAGTTTTTGCTCTGGTGAATTACATCTTCTTTAAAGGCAAACGAAGCGGATGCTGTGACACTGGATGCAGGTTTGGTG TATGATGCTTACCTGGCTCCCAATAACCTGAAGCCTGTGGTGGCAGAGTTCTATGGGTCAAAAGAGGATCCACAGACTTTCTATTATGCT GTTGCTGTGGTGAAGAAGGATAGTGGCTTCCAGATGAACCAGCTTCGAGGCAAGAAGTCCTGCCACACGGGTCTAGGCAGGTCCGCTGGG TGGAACATCCCCATAGGCTTACTTTACTGTGACTTACCTGAGCCACGTAAACCTCTTGAGAAAGCAGTGGCCAATTTCTTCTCGGGCAGC TGTGCCCCTTGTGCGGATGGGACGGACTTCCCCCAGCTGTGTCAACTGTGTCCAGGGTGTGGCTGCTCCACCCTTAACCAATACTTCGGC TACTCGGGAGCCTTCAAGTGTCTGAAGGATGGTGCTGGGGATGTGGCCTTTGTCAAGCACTCGACTATATTTGAGAACTTGGCAAACAAG GCTGACAGGGACCAGTATGAGCTGCTTTGCCTGGACAACACCCGGAAGCCGGTAGATGAATACAAGGACTGCCACTTGGCCCAGGTCCCT TCTCATACCGTCGTGGCCCGAAGTATGGGCGGCAAGGAGGACTTGATCTGGGAGCTTCTCAACCAGGCCCAGGAACATTTTGGCAAAGAC AAATCAAAAGAATTCCAACTATTCAGCTCTCCTCATGGGAAGGACCTGCTGTTTAAGGACTCTGCCCACGGGTTTTTAAAAGTCCCCCCC AGGATGGATGCCAAGATGTACCTGGGCTATGAGTATGTCACTGCCATCCGGAATCTACGGGAAGGCACATGCCCAGAAGCCCCAACAGAT GAATGCAAGCCTGTGAAGTGGTGTGCGCTGAGCCACCACGAGAGGCTCAAGTGTGATGAGTGGAGTGTTAACAGTGTAGGGAAAATAGAG TGTGTATCAGCAGAGACCACCGAAGACTGCATCGCCAAGATCATGAATGGAGAAGCTGATGCCATGAGCTTGGATGGAGGGTTTGTCTAC ATAGCGGGCAAGTGTGGTCTGGTGCCTGTCTTGGCAGAAAACTACAATAAGAGCGATAATTGTGAGGATACACCAGAGGCAGGGTATTTT GCTATAGCAGTGGTGAAGAAATCAGCTTCTGACCTCACCTGGGACAATCTGAAAGGCAAGAAGTCCTGCCATACGGCAGTTGGCAGAACC GCTGGCTGGAACATCCCCATGGGCCTGCTCTACAATAAGATCAACCACTGCAGATTTGATGAATTTTTCAGTGAAGGTTGTGCCCCTGGG TCTAAGAAAGACTCCAGTCTCTGTAAGCTGTGTATGGGCTCAGGCCTAAACCTGTGTGAACCCAACAACAAAGAGGGATACTACGGCTAC ACAGGCGCTTTCAGGTGTCTGGTTGAGAAGGGAGATGTGGCCTTTGTGAAACACCAGACTGTCCCACAGAACACTGGGGGAAAAAACCCT GATCCATGGGCTAAGAATCTGAATGAAAAAGACTATGAGTTGCTGTGCCTTGATGGTACCAGGAAACCTGTGGAGGAGTATGCGAACTGC CACCTGGCCAGAGCCCCGAATCACGCTGTGGTCACACGGAAAGATAAGGAAGCTTGCGTCCACAAGATATTACGTCAACAGCAGCACCTA TTTGGAAGCAACGTAACTGACTGCTCGGGCAACTTTTGTTTGTTCCGGTCGGAAACCAAGGACCTTCTGTTCAGAGATGACACAGTATGT TTGGCCAAACTTCATGACAGAAACACATATGAAAAATACTTAGGAGAAGAATATGTCAAGGCTGTTGGTAACCTGAGAAAATGCTCCACC TCATCACTCCTGGAAGCCTGCACTTTCCGTAGACCTTAAAATCTCAGAGGTAGGGCTGCCACCAAGGTGAAGATGGGAACGCAGATGATC CATGAGTTTGCCCTGGTTTCACTGGCCCAAGTGGTTTGTGCTAACCACGTCTGTCTTCACAGCTCTGTGTTGCCATGTGTGCTGAACAAA AAATAAAAATTATTATTGATTTTATATTTCAAAAACTCCATTCTTTCCTAAATATTTTCAACAAAGGATTTCTTTATGCATTCTGCCTAA ATACCTATGCAACTGAGCCCTTCCTTCTCAGCTCAAGATTCGTCTGGTCTTTCCCTACAGCTTTGTGTGTGCCATGGCCACATCTCCTGG >In-frame_ENST00000449399_ENST00000402696_TCGA-DD-A73C-01A_SERPINA1_chr14_94848929_-_TF_chr3_133472439_length(amino acids)=618AA_start in transcript=972_stop in transcript=2828 MDAGLVYDAYLAPNNLKPVVAEFYGSKEDPQTFYYAVAVVKKDSGFQMNQLRGKKSCHTGLGRSAGWNIPIGLLYCDLPEPRKPLEKAVA NFFSGSCAPCADGTDFPQLCQLCPGCGCSTLNQYFGYSGAFKCLKDGAGDVAFVKHSTIFENLANKADRDQYELLCLDNTRKPVDEYKDC HLAQVPSHTVVARSMGGKEDLIWELLNQAQEHFGKDKSKEFQLFSSPHGKDLLFKDSAHGFLKVPPRMDAKMYLGYEYVTAIRNLREGTC PEAPTDECKPVKWCALSHHERLKCDEWSVNSVGKIECVSAETTEDCIAKIMNGEADAMSLDGGFVYIAGKCGLVPVLAENYNKSDNCEDT PEAGYFAIAVVKKSASDLTWDNLKGKKSCHTAVGRTAGWNIPMGLLYNKINHCRFDEFFSEGCAPGSKKDSSLCKLCMGSGLNLCEPNNK EGYYGYTGAFRCLVEKGDVAFVKHQTVPQNTGGKNPDPWAKNLNEKDYELLCLDGTRKPVEEYANCHLARAPNHAVVTRKDKEACVHKIL -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for SERPINA1-TF |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for SERPINA1-TF |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for SERPINA1-TF |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | SERPINA1 | C0023895 | Liver diseases | 6 | CTD_human |
Hgene | SERPINA1 | C0086565 | Liver Dysfunction | 6 | CTD_human |
Hgene | SERPINA1 | C0221757 | alpha 1-Antitrypsin Deficiency | 6 | CTD_human;GENOMICS_ENGLAND |
Hgene | SERPINA1 | C0023890 | Liver Cirrhosis | 3 | CTD_human |
Hgene | SERPINA1 | C0239946 | Fibrosis, Liver | 3 | CTD_human |
Hgene | SERPINA1 | C0005586 | Bipolar Disorder | 2 | CTD_human;PSYGENET |
Hgene | SERPINA1 | C0024117 | Chronic Obstructive Airway Disease | 2 | CTD_human |
Hgene | SERPINA1 | C0030328 | Panniculitis, Nodular Nonsuppurative | 2 | CTD_human |
Hgene | SERPINA1 | C0525045 | Mood Disorders | 2 | PSYGENET |
Hgene | SERPINA1 | C1527303 | Chronic Airflow Obstruction | 2 | CTD_human |
Hgene | SERPINA1 | C2239176 | Liver carcinoma | 2 | CTD_human |
Hgene | SERPINA1 | C0001418 | Adenocarcinoma | 1 | CTD_human |
Hgene | SERPINA1 | C0003469 | Anxiety Disorders | 1 | CTD_human |
Hgene | SERPINA1 | C0003850 | Arteriosclerosis | 1 | CTD_human |
Hgene | SERPINA1 | C0003949 | Asbestosis | 1 | CTD_human |
Hgene | SERPINA1 | C0005587 | Depression, Bipolar | 1 | CTD_human |
Hgene | SERPINA1 | C0006267 | Bronchiectasis | 1 | CTD_human |
Hgene | SERPINA1 | C0008370 | Cholestasis | 1 | CTD_human |
Hgene | SERPINA1 | C0013221 | Drug toxicity | 1 | CTD_human |
Hgene | SERPINA1 | C0013990 | Pathological accumulation of air in tissues | 1 | CTD_human |
Hgene | SERPINA1 | C0019080 | Hemorrhage | 1 | CTD_human |
Hgene | SERPINA1 | C0019693 | HIV Infections | 1 | CTD_human |
Hgene | SERPINA1 | C0020615 | Hypoglycemia | 1 | CTD_human |
Hgene | SERPINA1 | C0022660 | Kidney Failure, Acute | 1 | CTD_human |
Hgene | SERPINA1 | C0024115 | Lung diseases | 1 | CTD_human;GENOMICS_ENGLAND |
Hgene | SERPINA1 | C0024121 | Lung Neoplasms | 1 | CTD_human |
Hgene | SERPINA1 | C0024623 | Malignant neoplasm of stomach | 1 | CTD_human |
Hgene | SERPINA1 | C0024713 | Manic Disorder | 1 | CTD_human |
Hgene | SERPINA1 | C0027627 | Neoplasm Metastasis | 1 | CTD_human |
Hgene | SERPINA1 | C0034067 | Pulmonary Emphysema | 1 | CTD_human |
Hgene | SERPINA1 | C0034069 | Pulmonary Fibrosis | 1 | CTD_human |
Hgene | SERPINA1 | C0038356 | Stomach Neoplasms | 1 | CTD_human |
Hgene | SERPINA1 | C0039841 | Thiamine Deficiency | 1 | CTD_human |
Hgene | SERPINA1 | C0041755 | Adverse reaction to drug | 1 | CTD_human |
Hgene | SERPINA1 | C0042384 | Vasculitis | 1 | CTD_human |
Hgene | SERPINA1 | C0205641 | Adenocarcinoma, Basal Cell | 1 | CTD_human |
Hgene | SERPINA1 | C0205642 | Adenocarcinoma, Oxyphilic | 1 | CTD_human |
Hgene | SERPINA1 | C0205643 | Carcinoma, Cribriform | 1 | CTD_human |
Hgene | SERPINA1 | C0205644 | Carcinoma, Granular Cell | 1 | CTD_human |
Hgene | SERPINA1 | C0205645 | Adenocarcinoma, Tubular | 1 | CTD_human |
Hgene | SERPINA1 | C0221227 | Centriacinar Emphysema | 1 | CTD_human |
Hgene | SERPINA1 | C0242379 | Malignant neoplasm of lung | 1 | CTD_human |
Hgene | SERPINA1 | C0264393 | Panacinar Emphysema | 1 | CTD_human |
Hgene | SERPINA1 | C0270715 | Degenerative Diseases, Central Nervous System | 1 | CTD_human |
Hgene | SERPINA1 | C0271708 | Fasting Hypoglycemia | 1 | CTD_human |
Hgene | SERPINA1 | C0271710 | Reactive hypoglycemia | 1 | CTD_human |
Hgene | SERPINA1 | C0338831 | Manic | 1 | CTD_human |
Hgene | SERPINA1 | C0376280 | Anxiety States, Neurotic | 1 | CTD_human |
Hgene | SERPINA1 | C0524851 | Neurodegenerative Disorders | 1 | CTD_human |
Hgene | SERPINA1 | C0751733 | Degenerative Diseases, Spinal Cord | 1 | CTD_human |
Hgene | SERPINA1 | C1279420 | Anxiety neurosis (finding) | 1 | CTD_human |
Hgene | SERPINA1 | C1565662 | Acute Kidney Insufficiency | 1 | CTD_human |
Hgene | SERPINA1 | C1708349 | Hereditary Diffuse Gastric Cancer | 1 | CTD_human |
Hgene | SERPINA1 | C2350878 | Focal Emphysema | 1 | CTD_human |
Hgene | SERPINA1 | C2609414 | Acute kidney injury | 1 | CTD_human |
Hgene | SERPINA1 | C2930617 | Pulmonary Fibrosis - from Asbestos Exposure | 1 | CTD_human |
Hgene | SERPINA1 | C2930967 | Gastro-enteropancreatic neuroendocrine tumor | 1 | CTD_human |
Hgene | SERPINA1 | C4505456 | HIV Coinfection | 1 | CTD_human |
Hgene | SERPINA1 | C4721507 | Alveolitis, Fibrosing | 1 | CTD_human |
Tgene | TF | C0521802 | Congenital atransferrinemia | 5 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Tgene | TF | C0036341 | Schizophrenia | 3 | PSYGENET |
Tgene | TF | C0001956 | Alcohol Use Disorder | 2 | CTD_human |
Tgene | TF | C0001973 | Alcoholic Intoxication, Chronic | 2 | CTD_human |
Tgene | TF | C0002395 | Alzheimer's Disease | 2 | CTD_human |
Tgene | TF | C0007097 | Carcinoma | 2 | CTD_human |
Tgene | TF | C0011265 | Presenile dementia | 2 | CTD_human |
Tgene | TF | C0015695 | Fatty Liver | 2 | CTD_human |
Tgene | TF | C0024667 | Animal Mammary Neoplasms | 2 | CTD_human |
Tgene | TF | C0024668 | Mammary Neoplasms, Experimental | 2 | CTD_human |
Tgene | TF | C0085762 | Alcohol abuse | 2 | CTD_human |
Tgene | TF | C0205696 | Anaplastic carcinoma | 2 | CTD_human |
Tgene | TF | C0205697 | Carcinoma, Spindle-Cell | 2 | CTD_human |
Tgene | TF | C0205698 | Undifferentiated carcinoma | 2 | CTD_human |
Tgene | TF | C0205699 | Carcinomatosis | 2 | CTD_human |
Tgene | TF | C0276496 | Familial Alzheimer Disease (FAD) | 2 | CTD_human |
Tgene | TF | C0494463 | Alzheimer Disease, Late Onset | 2 | CTD_human |
Tgene | TF | C0546126 | Acute Confusional Senile Dementia | 2 | CTD_human |
Tgene | TF | C0750900 | Alzheimer's Disease, Focal Onset | 2 | CTD_human |
Tgene | TF | C0750901 | Alzheimer Disease, Early Onset | 2 | CTD_human |
Tgene | TF | C1257925 | Mammary Carcinoma, Animal | 2 | CTD_human |
Tgene | TF | C2711227 | Steatohepatitis | 2 | CTD_human |
Tgene | TF | C0004352 | Autistic Disorder | 1 | CTD_human |
Tgene | TF | C0013221 | Drug toxicity | 1 | CTD_human |
Tgene | TF | C0013502 | Echinococcosis | 1 | CTD_human |
Tgene | TF | C0019158 | Hepatitis | 1 | CTD_human |
Tgene | TF | C0019193 | Hepatitis, Toxic | 1 | CTD_human |
Tgene | TF | C0021368 | Inflammation | 1 | CTD_human |
Tgene | TF | C0022660 | Kidney Failure, Acute | 1 | CTD_human |
Tgene | TF | C0027626 | Neoplasm Invasiveness | 1 | CTD_human |
Tgene | TF | C0027726 | Nephrotic Syndrome | 1 | CTD_human |
Tgene | TF | C0028754 | Obesity | 1 | CTD_human |
Tgene | TF | C0030524 | Paratuberculosis | 1 | CTD_human |
Tgene | TF | C0035258 | Restless Legs Syndrome | 1 | CTD_human |
Tgene | TF | C0041755 | Adverse reaction to drug | 1 | CTD_human |
Tgene | TF | C0152013 | Adenocarcinoma of lung (disorder) | 1 | CTD_human |
Tgene | TF | C0271901 | Microcytic hypochromic anemia (disorder) | 1 | CTD_human |
Tgene | TF | C0282193 | Iron Overload | 1 | CTD_human |
Tgene | TF | C0345967 | Malignant mesothelioma | 1 | CTD_human |
Tgene | TF | C0860207 | Drug-Induced Liver Disease | 1 | CTD_human |
Tgene | TF | C1262760 | Hepatitis, Drug-Induced | 1 | CTD_human |
Tgene | TF | C1565662 | Acute Kidney Insufficiency | 1 | CTD_human |
Tgene | TF | C2609414 | Acute kidney injury | 1 | CTD_human |
Tgene | TF | C3658290 | Drug-Induced Acute Liver Injury | 1 | CTD_human |
Tgene | TF | C4277682 | Chemical and Drug Induced Liver Injury | 1 | CTD_human |
Tgene | TF | C4279912 | Chemically-Induced Liver Toxicity | 1 | CTD_human |
Tgene | TF | C4553297 | Cystic Echinocccosis | 1 | CTD_human |